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o  The most common cause of dementia 
 
o  Neurodegenerative disease 
 
o  Progessive and Irreversible 
o  Cognitive Impairment and behavioural abnormalities 
 
o  Neuropathological alterations: β-amyloid, Tau hyperphosphoryation, 
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Characteristics      DONEPEZIL       RIVASTIGMINE   GALANTAMINE   MEMANTINE    
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Beta-amyloid remains a major target in all phases 
of clinical trials, despite high-profile failures in the 
past few years. 
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The greatest risk factor for AD is advanced age 
Aging	and	Development.	United	Nations	Development	Programme.	2015	Nov		




Culprits of the 
phenotype 
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Epigenetic landscape 1940 
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The three pillars of epigenetic regulations 
Gómez-Díaz E, Jordà M, Peinado MA, Rivero A (2012) Epigenetics of Host–Pathogen Interactions: The Road Ahead and the Road 
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Alterations of these epigenetic mechanisms 
Konar A, Singh P, Thakur MK. Age-associated Cognitive Decline: Insights into Molecular Switches and Recovery 
Avenues. Aging and Disease. 2016;7(2):121-129. doi:10.14336/AD.2015.1004. 
Alterations of these epigenetic mechanisms affect the vast majority of nuclear process, including: 
 
•  Gene transcription and silencing 
•  DNA replication and repair 
•  Cell cycle progression 
•  Telomere structure and function 
•  Mitochondrial function 
•  Inflammation  
•  Oxidative Stress 
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Bae B, Jayaraman D, Walsh CA. Genetic Changes Shaping the Human Brain. Developmental cell. 2015;32(4):423-434. 
 
 
The human brain expresses numerous genes; 
approximately 80–95%	
Levenson J. M., Sweatt J. D. (2005). Epigenetic mechanisms in memory formation. Nat. Rev. Neurosci. 6 108–118. 
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and	 histone	 modifications	 patterns,	 and	 further,	
that	 learning	 and	 memory	 depend	 on	 these	
epigenetic	changes.	
Levenson J. M., Sweatt J. D. (2005). Epigenetic mechanisms in memory formation. Nat. Rev. Neurosci. 6 108–118. 
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The aetiology of Alzheimer's disease is multifactorial. 
 
It is produced by a combination of genetic susceptibility factors added to exposure to 
environmental factors, where risk factors and protective factors interact, in a prolonged 
temporary sale that includes the aging process and with a different effect on each 
individual. 








2n Seminari de Recerca 2019 
Mecanismos epigenéticos  
en el deterioro cognitivo ligado al 
envejecimiento y enfermedad de 
Alzheimer             
Dimarts 14 de maig de 2019 
12:30 h 
Aula A4, Facultat de Farmàcia i Ciències de l’Alimentació 
Christian Griñán-Ferré 
Secció de Farmacologia 
 Dept. Farmacologia, Toxicologia i Química Terapèutica 












2n Seminari de Recerca 2019 
Mecanismos epigenéticos  
en el deterioro cognitivo ligado al 
envejecimiento y enfermedad de 
Alzheimer             
Dimarts 14 de maig de 2019 
12:30 h 
Aula A4, Facultat de Farmàcia i Ciències de l’Alimentació 
Christian Griñán-Ferré 
Secció de Farmacologia 
 Dept. Farmacologia, Toxicologia i Química Terapèutica 












SAM resistant (SAMR) mice 
 
Median survival 16.3 months  
SAM prone (SAMP) mice 
 




Dr. Takeda 1968 
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Effect of Environment enrichment (EE) in SAMP8 
Griñán-Ferré et al. Molecular Neurobiology, 2015 
Griñán-Ferré et al. Frontiers Aging Neurosci. 2016 
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Morris Water Maze 
Novel Object Recognition 










































































































































































SAMP8 EE  
SAMP8 CT  
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Griñán-Ferré et al. Frontiers Aging Neurosci. 2016 
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ê OXIDATIVE STRESS 
éNeuroprotection,éNeurogenesis 
ê Neuronal loss 
éCOGNITION 
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Epigenetics can explain in part 
the senescent phenotype that 
characterizes SAMP8 
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SAMR1 SAMP8 SAMR1 SAMP8 
Ac-H4 (17kDa)   
 
TBP (38kDa) 
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SAMR1 2 and 9 months (n=6) 
SAMP8 2 and 9 months (n=6) 
 microRNA PCR array
SAMR1 2 and 9 months (n=6)
SAMP8 2 and 9 months (n=6) 
1,062 mRNAs differenBally expressed in SAMP8 vs. SAMR1 at 2 months
1,033 mRNAs differenBally expressed in SAMP8 vs. SAMR1 at 9 months
92 mRNAs differenBally expressed in both 2 and 9 months





SelecBon of mRNAs:miRNAs pairs associated 
with aging, neurodegeneraBon and AD: 
3 putaBve mRNAs:miRNAs pairs in both 2 and 








(Table 3 and 














28 miRNAs differenBally expressed in SAMP8 vs. SAMR1 at 2 months
17 miRNAs differenBally expressed in SAMP8 vs. SAMR1 at 9 months
6 miRNAs differenBally expressed in both 2 and 9 months
(Figure 4 and Suppl. Material 4)
187 putaBve mRNAs:miRNAs pairs in 
2-month-old SAMP8 
(Table 1 and 2)
61 putaBve mRNAs:miRNAs pairs in 
9-month-old SAMP8 
(Table 1 and 2)
mRNAs:miRNAs interacBon
predicBons
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mRNA and miRNA expression profile 
We found 2,095 mRNA 
targets altered in SAMP8 
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Integrated mRNA:miRNA regulatory networks 
We found 174 mRNA targets 
altered in SAMP8 










2n Seminari de Recerca 2019 
Mecanismos epigenéticos  
en el deterioro cognitivo ligado al 
envejecimiento y enfermedad de 
Alzheimer             
Dimarts 14 de maig de 2019 
12:30 h 
Aula A4, Facultat de Farmàcia i Ciències de l’Alimentació 
Christian Griñán-Ferré 
Secció de Farmacologia 
 Dept. Farmacologia, Toxicologia i Química Terapèutica 




mmu-miR-298-5-p Regulation of membrane lipid distribution (GO: 0097035) 0.002603 -2.53 4.08
mmu-miR-151-3p Cellular response to extracellular stimulus (GO: 0031668) 0.002990 -2.26 3.66
mmu-miR148b-3p Regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO: 1902041) 0.005549 -2.37 3.33
mmu-let-7b-5p Wnt signaling pathway (GO: 0016055) 0.01844 -2.26 3.17
mmu-let-7e-5p Brain development (GO: 0007420) 0.01021 -2.25 3.16
Neuron-neuron synaptic transmission (GO: 0007270) 0.008912 -2.05 2.88
Insulin receptor signaling pathway (GO: 0008286) 0.04929 -1.97 2.77
Cellular ion homeostasis (GO: 0006873) 0.07075 -1.96 2.76
Positive regulation of neuron projection development (GO: 0010976) 0.04696 -1.89 2.65
Locomotor behavior (GO: 0007626) 0.07133 -1.83 2.57
mmu-miR-92a-3p Embryonic morphogenesis (GO: 0048598) 0.0007922 -2.40 6.34
mmu-miR-24-3p Brain development (GO: 0007420) 0.05911 -2.13 4.16
mmu-miR-27a-3p Synapse organization (GO: 0050808) 0.005018 -2.06 4.07
mmu-miR-30e-5p Neuron migration (GO: 0001764) 0.00583 -2.05 4.01
mmu-miR-107-3p Neuron development (GO: 0048666) 0.006725 -2.06 3.97
mmu-miR-26b-5p Behavior (GO: 0007610) 0.01035 -2.18 3.60
mmu-miR-7a-5p Regulation of synaptic transmission (GO: 0050804) 0.01713 -2.04 3.16
mmu-miR-181a-5p Response to oxygen levels (GO: 0070482) 0.02114 -2.09 3.11
mmu-miR-181d-5p Cellular senescence (GO: 0090398) 0.01385 -1.90 2.98
mmu-miR-132-3p Inflammatory response (GO: 0006954) 0.02707 -1.91 2.65
mmu-miR-146a-5p
mmu-miR-134-5p






Adam10, Bsn, Crcp, Csf3r, 
Ncan, Cyb561, Elk4, Gabrg2, 
Gata5, Gif, Slc6a9, H3f3b, Hlx, 
Hmg20b, Hyal1, Kif5b, Kpna1, 
Zfp239, Nsd1, Pde7a, Pik3ca, 
Pml, Pou3f2, Rab23, Ret, 
Rfng, Sema5a, Snca, Tarpb2, 
Tbx2r, Tgfbr1, Thrb, Unc5c, 
Nrsn1, Zhx1, Neurod6, 
Atp2b2, C3ar1, Casp6, Runx1, 
Cxcr4, En1, Esr2, Nr6a1, 
Gpr37, Hoxa5, Ids, Klf12, 
Matn3, Ndufs4, Pik3c2a, 
Ppara, Cyth3, Ptpre, Sncg, 
Tfeb, Tdg, Ercc5, Mrps12, 
Chst4, Add2, Crem, Eif4a2, 
Mmp9, Pam, Pax6, Sh3yl1, 
Mga, Rasal1, Slc33a1, Dkk3, 
Galns, Dnajc5, Irf6, Slc5a3, 
Chst2, Cldn8, Grpbp2, Rbms2, 
Plp2, Amotl2, Cyp2d22, Stx5a, 
C1qtnf1, Pnkd, Insm2, Srf, 
Nup160, Rhot1, Midn, Tsc1, 




Target mRNAs Top 10 GO Biological process  p-value Z-score Combined score
Adss,Ctnnd1, Comt1,Cyp7b1, 
Flt4, Ltf,Masp1, P2rx1, Pcp4, 
Nptn, Sepp1, Slc17a1, Atp8a1, 
Gabra1, Maff, Man1a2, Ndst2, 
Serf2, Skil, Coro1c, Abca1, 
Atp6v0d1, Tcp, Pdk4, Pbx3, 
Hp, Pdlim4, Ykt6, Kox17, 
Mesdc2, Tmem167, Serbp1, 
Lipt2, Atg12, Loh12cr1, 
Mrpl19, Manba, Trps1, 
Kremen1.
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mmu-miR-128-3p Memory (GO: 0007613) 0.001378 -2.23 4.11
mmu-miR-140-5p Response to tumor necrosis factor (GO: 0034612) 0.002467 -2.31 3.96
mmu-miR-148b-3p Synaptic transmission (GO: 0007268) 0.003559 -2.32 3.88
mmu-miR-342-3p Activation of innate immune response (GO: 0002218) 0.005741 -2.21 3.70
mmu-miR-98-5p Learning or memory (GO:0007611) 0.01189 -2.20 3.63
mmu-miR-107-3p Cognition (GO: 0050890) 0.01703 -2.16 3.57
Positive regulation of canonical Wnt signaling pathway (GO: 0090263) 0.009200 -2.11 3.49
Cellular response to unfolded protein (GO: 0034620) 0.01849 -2.01 3.32
Neuron-neuron synaptic transmission (GO: 0007270) 0.008912 -2.01 3.32
Response to carbohydrate (GO: 0009743) 0.04411 -1.89 3.11
mmu-let-7b-5p Positive regulation of cell cycle G2/M phase transition (GO:1902751) 0.004199 -2.74 9.30
mmu-let-7c-5p Positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) 0.004199 -2.74 9.29
mmu-let-7d-5p Positive regulation of mitotic cell cycle (GO:0045931) 0.02884 -2.15 6.24
mmu-let-7e-5p Intracellular steroid hormone receptor signaling pathway (GO:0030518) 0.02059 -2.07 6.09
Negative regulation of sequence-specific DNA binding Transcription factor activity (GO:0043433) 0.03514 -2.10 5.95
Histone acetylation (GO:0016573) 0.02829 -2.05 5.93
Developmental growth (GO:0048589) 0.04520 -2.16 5.83
Negative regulation of neuron differentiation (GO:0045665) 0.04085 -2.15 5.83
Positive regulation of cell cycle process (GO:0090068) 0.06054 -2.29 5.74
Negative regulation of neurogenesis (GO:0050768) 0.05032 -2.14 5.56
Capza2, Cav1, Chuk, Dll3, 
Drd4, Pdia3, Gcdh, Gria1, 
H3f3b, Htr1f, Kcnj8, Dnajc3, 
Clpb, Itga5, Itk, Cyth3, 
Hsp90b1, Hs2st1, Spry4, 
Map2k7, Fgf9, Atp11a, Mapk6, 
Slc5a3, Socs6, Thsd1, 
B3galtn1, Kcna4, Txnip, 
Vps50, Arl4d, Cdip1, Mmachc, 
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The selected mRNA:miRNA pairs are involved in brain  
aging and neurodegeneration. 
Validation of mRNA:miRNA pairs 
A                     2-month-old	 B                   2-month-old	
C                     2-month-old	 D                  9-month-old	
E                    9-month-old	 F                   2-month-old	











































































































































































































































































































































































































































•  Purinergic signaling 
     P2rx1 
•  Inflammatory process 
     Socs6 
•  Neuron 
differentiation 
     Pou3f2, Hmg20b  
•  Neurogenesis 
     Pbx1 
•  Protein trafficking 
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Unpublished results  
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Unpublished results  
Proof-of-Concept (PoC) 
 
UNC0642 an in vivo  
BBB penetrant 
 G9a inhibitor 
IC50 < 2.5 nM 
 
1.  SAMP8 and 5XFAD are a suitable model to study ageing processes, 
including AD. 
 
2.  EE, as a tool to unveil epigenetic influence in senescence process, 
supported the hypothesis of epigenetic control in ageing in SAMP8. 
 
3.  Our data indicate the reciprocal interaction between non-genetic factors 
and epigenetic mechanisms that can explain the senescence process in the 
SAMP8. 
4.  miRNA have a pivotal role in gene regulation in SAMP8. 
 
5.  The different pathological process that suffer SAMP8 and 5XFAD, will allow 
to use them an in vivo model for drug discovery in neurosciences, by using 
a broad number of different targets related with inflammation, oxidative 
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